Free Trial

Tarsus Pharmaceuticals (TARS) SEC Filings & 10K Form

Tarsus Pharmaceuticals logo
$42.56 -0.41 (-0.94%)
As of 10:43 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent Tarsus Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/07/2025
10:27 AM
MORGAN STANLEY (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
05/01/2025
3:10 PM
Tarsus Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/28/2025
3:09 PM
Tarsus Pharmaceuticals (Filer)
Form ARS
04/24/2025
8:12 AM
BlackRock, Inc. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
03/26/2025
3:47 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/24/2025
4:35 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
8:49 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM
Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:48 PM
Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:49 PM
Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
8:49 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2025
3:29 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:30 PM
Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:35 PM
Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:18 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:21 PM
Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/20/2025
3:11 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:24 PM
Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:27 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:22 PM
Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:23 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:12 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/19/2025
2:12 PM
Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
8:38 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM
Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:39 PM
Tarsus Pharmaceuticals (Issuer)
Whitfield Dianne C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:40 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
8:40 PM
Farrow Jeffrey S (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2025
3:26 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:26 PM
Tarsus Pharmaceuticals (Subject)
Wahl Bryan (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:31 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
3:20 PM
Tarsus Pharmaceuticals (Subject)
Whitfield Dianne C. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/13/2025
3:37 PM
Tarsus Pharmaceuticals (Filer)
Form 424B5
03/13/2025
3:40 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/12/2025
3:26 PM
Tarsus Pharmaceuticals (Filer)
Form 424B5
03/07/2025
3:17 PM
Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:17 PM
Azamian Bobak R. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:18 PM
Tarsus Pharmaceuticals (Issuer)
Wahl Bryan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2025
3:19 PM
Neervannan Seshadri (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
How Trade Wars Are Creating Fresh Opportunities for Investors (Ad)

Tariffs and trade tensions are back in the headlines, and while many are focused on the risks, smart investors know there’s also opportunity. New supply chain shifts, pricing power adjustments, and sector revaluations are already underway—creating openings for those who act early. That’s why we’ve just released our latest research: 📈 “From Tariffs to Returns: How to Capitalize on Trade Disputes in Your Portfolio”

Position yourself ahead of the next move—get the full report here.
03/07/2025
3:19 PM
Mottiwala Aziz (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
6:07 AM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/13/2025
11:22 AM
Cowen Financial Products LLC (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
01/17/2025
4:08 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2025
7:30 AM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
4:03 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
2:05 PM
Cormorant Asset Management, LP (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
11/13/2024
3:06 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2024
3:40 PM
Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2024
9:26 AM
Frazier Life Sciences IX, L.P. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
11/05/2024
3:06 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
1:00 PM
Tarsus Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/21/2024
3:11 PM
BlackRock, Inc. (Filed by)
Tarsus Pharmaceuticals (Subject)
Form SC 13G/A
10/02/2024
4:27 PM
Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:52 PM
Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:34 PM
LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:21 PM
Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:22 PM
CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:23 PM
Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:24 PM
Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:25 PM
LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:26 PM
Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2024
5:26 PM
Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2024
3:26 PM
Tarsus Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2024
4:44 PM
CHAUDHURI BHASKAR (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:45 PM
Goldberg Andrew D. (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:33 PM
Lin Elizabeth Yeu (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:38 PM
Tarsus Pharmaceuticals (Issuer)
YARNO WENDY L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:40 PM
Crane Rosemary A (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:28 PM
LINK WILLIAM J PHD (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/14/2024
4:30 PM
Morrison Scott W (Reporting)
Tarsus Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:TARS) was last updated on 5/23/2025 by MarketBeat.com Staff
From Our Partners